PDIL5-1 Antibody

What is PDIL5-1 and why is it significant in plant virus research?

PDIL5-1 (PROTEIN DISULFIDE ISOMERASE LIKE 5-1) is a member of the protein disulfide isomerase (PDI) gene family that functions as a susceptibility factor for bymoviruses in barley. The protein contains a single functional thioredoxin (TRX) domain that catalyzes the formation, reduction, and isomerization of disulfide bonds, and includes a C′-terminal tetrapeptide EDEL that controls retention in the endoplasmic reticulum (ER) .

PDIL5-1 is particularly significant because:

• Loss-of-function mutations in PDIL5-1 confer broad-spectrum resistance to multiple strains of Bymoviruses including Barley yellow mosaic virus (BaYMV) and Barley mild mosaic virus (BaMMV)

• It represents a distinct mechanism of recessive resistance where the absence of a functional host factor prevents virus multiplication

• The protein is highly conserved across eukaryotes, suggesting potential roles of PDI family members as susceptibility factors in other plant-virus pathosystems

• Understanding PDIL5-1 has direct applications in developing virus-resistant crop varieties through various breeding and gene editing approaches

How should I design epitopes for PDIL5-1 antibody development?

When designing epitopes for PDIL5-1 antibody development, consider the protein's structural and functional domains:

• Thioredoxin domain targeting: Focus on the conserved functional domain containing the Cys-x-x-Cys active center that is critical for catalytic activity .

• C-terminal region specificity: The C′-terminal tetrapeptide EDEL controls ER retention and differs between monocots and dicots, making it useful for developing species-specific antibodies .

• Variant-specific epitopes: For detecting resistance-conferring alleles, design peptides that span mutation sites or novel junctions created by deletions or frameshifts .

• Cross-reactivity considerations: PDIL5-1 is part of a gene family with high sequence conservation; analyze sequence alignments to identify regions unique to PDIL5-1 to avoid cross-reactivity with other PDI family members .

• 3D structure awareness: Consider the highly conserved tertiary structure of PDIL5-1 across species when designing conformational epitopes .

What validation methods should I use for PDIL5-1 antibodies?

A comprehensive validation strategy for PDIL5-1 antibodies should include:

Genetic validation:

• Testing with PDIL5-1 knockout mutants (EMS-induced or CRISPR-Cas9 generated) to confirm absence of signal

• Comparing signals between wild-type plants and those carrying natural resistance alleles (rym11-a, -b, -c, or -d)

Biochemical validation:

• Western blotting with recombinant PDIL5-1 protein as positive control

• Peptide competition assays to demonstrate binding specificity

• Testing against other PDI family members to assess cross-reactivity

Functional validation:

• Immunoprecipitation followed by mass spectrometry to confirm target identity

• Testing reactivity in complementation lines where wild-type PDIL5-1 has been reintroduced into resistant lines

Application-specific validation:

• For immunohistochemistry: comparing localization patterns with known ER markers

• For virus-host interaction studies: verifying detection in both infected and non-infected tissues

How can I use PDIL5-1 antibodies to study virus-host interactions in barley?

PDIL5-1 antibodies provide powerful tools for investigating the molecular mechanisms of bymovirus infection in barley:

Protein-virus interaction studies:

• Immunoprecipitate PDIL5-1 during virus infection to identify viral proteins that directly interact with this host factor

• Perform proximity ligation assays to visualize and quantify PDIL5-1-virus protein interactions in situ

Subcellular localization dynamics:

• Track changes in PDIL5-1 distribution during different stages of virus infection using immunofluorescence microscopy

• Determine if PDIL5-1 is recruited to viral replication complexes or modified during infection

Comparative proteomics:

• Use PDIL5-1 antibodies for pull-down assays followed by mass spectrometry to identify differential protein interactions in resistant versus susceptible barley varieties

• Analyze post-translational modifications of PDIL5-1 that may be induced during virus infection

Virus resistance mechanisms:

• Investigate whether virus resistance in PDIL5-1 mutants is due to inability of viral proteins to interact with the modified host factor

• Compare the chaperone activity of wild-type versus mutant PDIL5-1 proteins to understand functional requirements for virus susceptibility

What are the differences in designing antibodies for wild-type versus mutant PDIL5-1 variants?

Designing antibodies that distinguish between wild-type and mutant PDIL5-1 variants requires different strategies based on the nature of the mutations:

For antibodies that recognize all PDIL5-1 variants:

• Target conserved N-terminal regions present in both wild-type and mutant proteins

• Use regions outside known mutation hotspots

For variant-specific antibodies:

• Employ rigorous screening against multiple variants

• Consider phage display technology for selecting high-specificity antibody variants

• Validate with known plant genotypes carrying different PDIL5-1 alleles

How can PDIL5-1 antibodies be used to screen germplasm for natural resistance sources?

PDIL5-1 antibodies offer an efficient approach for screening barley germplasm collections to identify accessions with potentially resistance-conferring PDIL5-1 variants:

Screening methodology:

• Develop a panel of antibodies targeting different regions of PDIL5-1, including:

  • Antibodies recognizing wild-type protein

  • Antibodies specific to known resistance-conferring variants

  • Antibodies targeting conserved regions present in both functional and non-functional variants

• Design a high-throughput screening protocol:

  • Extract proteins from leaf samples of germplasm accessions

  • Perform dot blot or ELISA-based screening with the antibody panel

  • Identify accessions showing patterns consistent with known resistance alleles

• Validation of potential resistance sources:

  • Confirm antibody results with genotyping of the PDIL5-1 locus

  • Test virus resistance through mechanical inoculation with BaMMV/BaYMV

  • Perform DAS-ELISA with virus-specific antibodies to verify resistance

Geographic considerations:

• Focus screening efforts on East Asian accessions, where resistance alleles show higher frequency (up to 6.56% for some haplotypes)

• Compare with European accessions where resistance alleles are rare despite bymovirus presence

This antibody-based approach could complement existing PCR-based genotyping methods and potentially identify novel resistance-conferring variants.

How do I develop an immunoassay to detect PDIL5-1-virus protein complexes during infection?

Developing an immunoassay to detect PDIL5-1-virus protein complexes requires capturing transient interactions that occur during the infection process:

Co-immunoprecipitation approach:

• Sample preparation optimization:

  • Collect tissue at multiple timepoints post-infection to capture different stages of the virus lifecycle

  • Use mild detergents (0.5-1% NP-40 or Triton X-100) to preserve protein-protein interactions

  • Include protease and phosphatase inhibitors to prevent degradation of complexes

  • Consider in vivo crosslinking with formaldehyde to stabilize transient interactions

• Immunoprecipitation strategy:

  • Use anti-PDIL5-1 antibodies conjugated to magnetic beads or Protein A/G

  • Perform reciprocal IPs using antibodies against viral proteins (coat protein or replicase)

  • Include appropriate controls (non-infected tissue, isotype control antibodies)

• Detection methods:

  • Western blot to identify specific viral proteins co-precipitating with PDIL5-1

  • Mass spectrometry for unbiased identification of all interacting proteins

  • RNA analysis of precipitated complexes to detect any associated viral RNA

• Validation approaches:

  • Perform studies in both susceptible varieties and those expressing resistance-conferring PDIL5-1 variants

  • Use proximity ligation assay (PLA) as an orthogonal method to visualize interactions in situ

  • Compare results between different bymovirus strains to identify strain-specific interactions

This methodology would help elucidate how PDIL5-1 functions as a susceptibility factor for bymoviruses and potentially identify targets for engineering resistance.

What approaches can distinguish between direct and indirect roles of PDIL5-1 in virus infection?

Distinguishing between direct and indirect roles of PDIL5-1 in bymovirus infection requires multiple complementary experimental approaches:

Direct interaction assessment:

• In vitro binding assays with purified recombinant PDIL5-1 and viral proteins

• Yeast two-hybrid or split-ubiquitin assays to test direct protein-protein interactions

• Surface plasmon resonance to measure binding kinetics and affinity constants

• FRET/BRET assays in plant cells to detect direct interactions in vivo

Functional domain analysis:

• Generate PDIL5-1 variants with mutations in the active site (Cys-x-x-Cys motif) to assess if catalytic activity is required for virus susceptibility

• Test PDIL5-1 with mutations in the EDEL motif to determine if ER localization is essential

• Complement resistant plants with chimeric proteins combining domains from PDIL5-1 and other PDI family members

Temporal analysis:

• Use time-course experiments with PDIL5-1 antibodies to track protein modifications during virus infection

• Compare timing of PDIL5-1 involvement with known stages of the virus infection cycle

Comparative analysis with related viruses:

• Test if PDIL5-1 is required for infection by other members of the Potyviridae family

• Identify viral proteins from different viruses that interact with PDIL5-1

This multilayered approach would help determine whether PDIL5-1 directly interacts with viral components or indirectly creates a cellular environment conducive to virus replication and spread.

What is the optimal protocol for immunohistochemical detection of PDIL5-1 in barley tissues?

The following optimized protocol ensures effective immunohistochemical detection of PDIL5-1 in barley tissues, accounting for its ER localization and plant tissue-specific challenges:

Tissue Fixation and Processing:

• Fix freshly collected barley leaf tissue in 4% paraformaldehyde in phosphate buffer (pH 7.4) for 4 hours at room temperature

• Wash 3× in phosphate buffer (15 minutes each)

• Dehydrate through an ethanol series (30%, 50%, 70%, 85%, 95%, 100%, 100%; 1 hour each)

• Infiltrate with paraffin through an ethanol:xylene:paraffin series

• Embed in paraffin and section at 5-7 μm thickness

Immunohistochemical Staining:

• Deparaffinize sections in xylene (2× 10 minutes) and rehydrate through a descending ethanol series

• Perform antigen retrieval: 10 mM sodium citrate buffer (pH 6.0) at 95°C for 10 minutes

• Cool to room temperature and wash in PBS (3× 5 minutes)

• Block endogenous peroxidase activity with 3% H₂O₂ in methanol (10 minutes)

• Block non-specific binding with 5% normal goat serum in PBS with 0.1% Triton X-100 (1 hour)

• Incubate with primary anti-PDIL5-1 antibody (1:100-1:200 dilution) in blocking buffer overnight at 4°C

• Wash in PBS with 0.1% Tween-20 (3× 10 minutes)

• Incubate with appropriate secondary antibody (HRP or fluorescently labeled) for 1-2 hours at room temperature

• Wash in PBS with 0.1% Tween-20 (3× 10 minutes)

• For HRP detection: develop with DAB substrate until signal appears

• For fluorescence detection: proceed directly to counterstaining

• Counterstain nuclei with DAPI (1 μg/mL, 5 minutes)

• Mount in appropriate medium (anti-fade mounting medium for fluorescence)

Critical Controls:

• Include sections from PDIL5-1 knockout plants (CRISPR-modified or natural rym11 variants)

• Use pre-immune serum as a negative control

• Include ER marker antibodies for co-localization studies

This protocol can be adapted for confocal microscopy to provide high-resolution imaging of PDIL5-1 localization during virus infection.

How do I optimize western blot conditions for detecting PDIL5-1 in plant extracts?

Optimizing western blot conditions for PDIL5-1 detection in plant extracts requires special considerations for this small ER-resident protein:

Sample Preparation:

• Grind tissue in liquid nitrogen to a fine powder

• Extract with buffer containing:

  • 50 mM Tris-HCl pH 7.5

  • 150 mM NaCl

  • 1% Triton X-100

  • 0.5% sodium deoxycholate

  • 5 mM EDTA

  • 1 mM DTT

  • Protease inhibitor cocktail

• Centrifuge at 16,000 × g for 15 minutes at 4°C

• Collect supernatant and determine protein concentration

Gel Electrophoresis:

• Use 15% SDS-PAGE gel (PDIL5-1 is approximately 17 kDa based on its 151 amino acids)

• Load 30-50 μg total protein per lane

• Include recombinant PDIL5-1 as positive control

• Run at 100V until dye front reaches bottom

Transfer:

• Use PVDF membrane (0.2 μm pore size)

• Transfer at 25V overnight at 4°C or 100V for 1 hour in cold room

• Verify transfer with Ponceau S staining

Immunodetection:

• Block membrane with 5% non-fat dry milk in TBST for 1 hour

• Incubate with primary anti-PDIL5-1 antibody (1:1000 dilution) overnight at 4°C

• Wash 3× with TBST (10 minutes each)

• Incubate with HRP-conjugated secondary antibody (1:5000) for 1 hour

• Wash 3× with TBST (10 minutes each)

• Develop using ECL substrate with extended exposure times if needed

Critical Optimization Parameters:

• Test different antibody dilutions (1:500 to 1:2000)

• Evaluate different blocking agents (BSA vs. non-fat dry milk)

• Compare different detection systems (chemiluminescence vs. fluorescence)

• Include appropriate loading controls (e.g., actin, GAPDH)

This optimized protocol should enable reliable detection of PDIL5-1 in barley and other plant extracts.

What are the best methods for purifying recombinant PDIL5-1 for antibody production?

The following protocol is optimized for producing high-quality recombinant PDIL5-1 suitable for antibody development:

Expression System Selection:

• E. coli BL21(DE3) with pET vector system for high expression

• Consider Origami™ strains with oxidizing cytoplasm for proper disulfide bond formation

Construct Design:

• Clone the full-length 456 bp ORF of PDIL5-1

• Add N-terminal 6×His tag with TEV protease cleavage site

• Remove C-terminal EDEL retention signal if expressed in eukaryotic systems

Expression Conditions:

• Transform expression host with validated construct

• Grow culture to OD₆₀₀ of 0.6-0.8 at 37°C

• Induce with 0.5 mM IPTG

• Shift temperature to 18°C and continue expression for 16-18 hours

• Harvest cells by centrifugation

Purification Protocol:

• Resuspend cell pellet in lysis buffer:

  • 50 mM Tris-HCl pH 8.0

  • 300 mM NaCl

  • 10 mM imidazole

  • 5 mM β-mercaptoethanol

  • 1 mM PMSF

  • Protease inhibitor cocktail

• Lyse cells by sonication or French press

• Clarify lysate by centrifugation at 20,000 × g for 30 minutes at 4°C

• Purify using Ni-NTA affinity chromatography:

  • Wash with 20-30 mM imidazole

  • Elute with 250 mM imidazole

• Remove imidazole by dialysis against:

  • 20 mM Tris-HCl pH 7.5

  • 150 mM NaCl

  • 2 mM DTT

• Optional: Remove His-tag with TEV protease

• Perform size exclusion chromatography to obtain homogeneous protein

Quality Control:

• Verify purity by SDS-PAGE (>90% purity required)

• Confirm identity by mass spectrometry

• Test enzymatic activity using disulfide isomerase assay

• Assess protein folding by circular dichroism

This purification strategy has been successfully used to obtain functional recombinant proteins from the PDI family for structural and functional studies.

How can I design a multiplex detection system for various PDIL5-1 alleles?

A multiplex detection system for various PDIL5-1 alleles would be valuable for screening germplasm and breeding populations. Here's how to develop such a system:

Antibody-Based Multiplex System:

• Panel design for known resistance alleles:

• Multiplexed ELISA format:

  • Coat plates with different anti-PDIL5-1 variant antibodies in separate wells

  • Apply plant extract samples to all wells

  • Detect using biotinylated secondary antibody and streptavidin-HRP

  • Pattern of positive/negative signals identifies the allele present

• Antibody array approach:

  • Spot variant-specific antibodies on membrane or glass slide

  • Apply fluorescently labeled plant extract

  • Pattern of binding reveals allele identity

• Flow cytometry-based detection:

  • Conjugate different fluorophores to variant-specific antibodies

  • React with plant extract containing membrane fractions

  • Analyze fluorescence patterns to identify alleles

Complementary DNA-based detection:

• Develop KASP markers for key SNPs and indels in PDIL5-1

• Design multiplex PCR to simultaneously detect multiple alleles

• Use as validation for antibody-based detection systems

This multiplex system would facilitate rapid screening of germplasm collections and breeding lines for PDIL5-1 variants associated with bymovirus resistance.

What controls and validation steps are essential when using PDIL5-1 antibodies for virus-host interaction studies?

For robust virus-host interaction studies using PDIL5-1 antibodies, the following controls and validation steps are essential:

Genetic Controls:

• Positive controls:

  • Wild-type barley varieties known to express functional PDIL5-1 (e.g., 'Naturel', 'Igri')

  • Transgenic complementation lines where PDIL5-1 has been reintroduced into resistant varieties

• Negative controls:

  • PDIL5-1 knockout mutants generated by CRISPR-Cas9

  • Natural resistance lines carrying different rym11 alleles

  • TILLING-derived mutants with premature stop codons in PDIL5-1

Experimental Controls:

• Antibody specificity controls:

  • Pre-immune serum or isotype controls

  • Peptide competition assays (pre-incubating antibody with excess antigen)

  • Signal absence verification in known knockout tissues

• Infection status controls:

  • Parallel analysis of infected and non-infected tissues

  • Time-course sampling to track changes during infection progression

  • DAS-ELISA to confirm virus presence/absence

Validation Approaches:

• Biochemical validation:

  • Confirm protein-protein interactions using multiple methods (co-IP, PLA, FRET)

  • Validate antibody specificity against recombinant wild-type and mutant proteins

  • Use mass spectrometry to confirm identity of immunoprecipitated proteins

• Functional validation:

  • Compare antibody results with phenotypic virus resistance/susceptibility

  • Correlate protein interactions with virus accumulation measured by ELISA

  • Test interactions with multiple virus strains to confirm specificity

• Localization validation:

  • Co-localization studies with established organelle markers

  • Compare localization patterns before and during infection

  • Verify changes in localization using multiple microscopy techniques

These comprehensive controls and validation steps will ensure reliable and reproducible results when using PDIL5-1 antibodies to study virus-host interactions.